Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

The story does a good job of pointing out one advantage of the pill approach compared to delivery via colonoscopy–the reduced cost. “There was a significant difference in cost. Though the procedures were done in a Canadian hospital, the FMTs delivered by colonoscopy cost nearly $500 USD more than the capsules, which cost about $300.” This was a close call. Early on, it says the pill was 90% effective for treating recurrent Clostridium difficile infections. Later on, the story explains that both were equally successful in treating the Clostridium difficile infections. It would take a bit of deduction to figure out that the 90% treatment rate applies to both the pills and colonoscopies. And the study puts this figure close to 96%. But we’ll give the benefit of the doubt and rate it satisfactory. The story gets a satisfactory here for including the differences between the two methods of delivery: One source is quoted saying, “colonoscopies and the anesthesia required for the procedure can put a lot of stress on a person’s body and can be complicated for the people most at risk for C. difficile infections.”  It could have gone a step further and reminded readers that a colonoscopy is an invasive procedure with the inherent risks of infection and perforation that obviously aren’t there when taking a pill. The story did not mention the other adverse events described in the paper such as nausea and vomiting, though. The story comments on the size of the study and quotes a researcher about strengths (a randomized, controlled trial) and limitations (selection bias) of the study. Selection bias, in this case, means many people were excluded from the clinical trial if they had any number of issues (patients with severe or complicated cases were excluded, for example), potentially biasing the results. In a more real-world setting, the effectiveness rate may drop once it’s tried on a wider range of people. No disease mongering here. The story does include comments from an independent source unaffiliated with the research. But, it doesn’t specify that the source has received research money from a drug company that’s developing microbiome drugs. Standard treatment for C. diff is antibiotics. This should have been mentioned. Unfortunately, the story doesn’t spell out whether the pill form FMT is now, or soon will be, available to the public. The story does mention that numerous other clinical trials are using FMT as a possible treatment for various diseases but it is unclear whether the pill form is an option for physicians at this point. What’s new here is that a pill form for delivery of a fecal transplant is being tested against a colonoscopy. The story established this. It does not appear to rely on a news release.
Fecal transplant via a pill? Newsweek’s coverage points out possible selection bias of study participants

The nation’s disaster risk management office says 1,192 cases have been identified. More than two-thirds of cases are of the more virulent pneumonic form. The office says less than 30 percent of people who have had contact with plague patients can be traced, making it more difficult to control the spread of the disease. Plague is endemic in Madagascar. This year’s outbreak is unusual because it has reached the nation’s two largest cities, Antananarivo and Toamasina.
Madagascar’s plague deaths up to 124, island nation says.

"As schools across the country open for the uncertain, unprecedented school year to come, opinions are split on how to do so safely. Some districts have opted for completely virtual learning. Others will try a mix of both online and in-person classes, or will send younger children to school while older kids stay home, or will phase students back to the classroom gradually. Others still are calling for schools to reopen completely for those who feel well enough to teach and attend, and who aren’t especially vulnerable to COVID-19. One such voice is U.S. Sen. Ron Johnson, R-Wisconsin, who in an Aug. 13, 2020 radio interview with Milwaukee talk show host Steve Scaffidi on WTMJ-AM discussed why he believes students need to return to school in person this fall. For younger people, Johnson asserted, ""seasonal flu is actually, in many cases, a deadlier virus if they contract that."" Is Johnson correct that COVID-19 is less deadly for children than the flu? Let’s dig in. COVID was less harsh on kids than the flu, this year’s stats show To back up his claim, Johnson’s office sent statistics from the Centers for Disease Control and Prevention on flu and COVID-19 deaths among Americans under age 18. During the 2018-19 flu season, the CDC reported approximately 480 flu deaths among children ages 0-17, about 30% of whom had a lab-confirmed case of influenza. Comparably, 90 American youth have died from coronavirus complications from the beginning of the pandemic through mid-August, according to the American Academy of Pediatrics. More than 46,000 children were hospitalized for flu in that 2018-19 period. The hospitalization rate among children 5 to 17 was 39.2 children per 100,000 children. For COVID-19, that hospitalization rate is 6 per 100,000 children ages 5 to 17, the CDC says. In a report detailing the differences between COVID-19 and the flu, the CDC states that ""the risk of complications for healthy children is higher for flu compared to COVID-19."" And data from Wisconsin echoes that sentiment. Since the pandemic began, no children have died from COVID-19 complications, according to state Department of Health Services death data, and 147 people ages 0-19 have been hospitalized. In contrast, three pediatric flu deaths occurred during this year’s flu season, DHS data show, and 605 kids ages 17 and under have been hospitalized. The data show there have been fewer childhood deaths from COVID-19 so far this year than from the seasonal flu. The hold-up, of course, lies in nuance, said Dr. Jon Temte, associate dean for public health and community engagement within UW-Madison’s School of Medicine and Public Health. ""U.S. schools have been out (and) mostly closed since March, thus extremely limiting cases of SARS-CoV-2 in children. Conversely, we rarely close schools for influenza, thus allowing an attack rate of 30-40% in school-aged children,"" Temte wrote in an Aug. 27, 2020 email to PolitiFact Wisconsin. That is, the flu has been able to spread through children more commonly than COVID-19, creating more cases, more complications and more deaths. Other experts agree. Dr. Chad Vercio, chair of pediatrics at Riverside University Health System in California, said children’s risk from the coronavirus depends on how widespread the virus is in any given area, and that ""it is unknown"" if COVID hospitalization rates would rise once schools reopen. And though the early data suggests that COVID-19 is not as bad for children as the flu, it’s just that: Early. Dr. Vidya Mony, an infectious disease expert with Santa Clara Valley Medical Center in San Jose, Calif., said there isn’t enough data yet to say indisputably that COVID risks are lower for kids. Johnson claimed that in many cases, the seasonal flu was a deadlier virus for youth than COVID-19. The numbers show that this year, that was the case. More children died from flu complications than from COVID-19, and were hospitalized at higher rates for the flu. But experts caution that we don’t have enough data to paint the full picture so early in the game, and that schools shutting down in early spring may have driven down coronavirus case rates in children — meaning we can’t be sure exactly how the virus will move through young people when more of them are potentially getting exposed. Our definition for  is ""the statement is accurate but needs clarification or additional information."" That fits here."

For younger people, seasonal flu is “in many cases” a deadlier virus than COVID-19